Terms: = Pancreatic cancer AND CASP8, ALPS2B, 841, ENSG00000064012, MGC78473, CAP4, MACH, MCH5, FLICE AND Diagnosis
18 results:
1. Establishment and external validation of prognosis prediction nomogram for patients with distant metastatic intrahepatic cholangiocarcinoma: based on a large population.
Yuan C; Zou S; Wang K; Hu Z
BMC Cancer; 2024 Feb; 24(1):227. PubMed ID: 38365630
[TBL] [Abstract] [Full Text] [Related]
2. Does Oral Microbiota Have a Close Relationship with pancreatic cancer? A Systematic Review and Meta-Analysis.
Ma H; Luo W; Gu Y
Ann Surg Oncol; 2023 Dec; 30(13):8635-8641. PubMed ID: 37787951
[TBL] [Abstract] [Full Text] [Related]
3. MRI-Based Radiomics Nomogram for Preoperatively Differentiating Intrahepatic Mass-Forming Cholangiocarcinoma From Resectable Colorectal Liver Metastases.
Xu Y; Ye F; Li L; Yang Y; Ouyang J; Zhou Y; Wang S; Xie L; Zhou J; Zhao H; Zhao X
Acad Radiol; 2023 Sep; 30(9):2010-2020. PubMed ID: 37414635
[TBL] [Abstract] [Full Text] [Related]
4. A nomogram-based model and ultrasonic radiomic features for gallbladder polyp classification.
Zhang X; Wang J; Wu B; Li T; Jin L; Wu Y; Gao P; Zhang Z; Qin X; Zhu C
J Gastroenterol Hepatol; 2022 Jul; 37(7):1380-1388. PubMed ID: 35357026
[TBL] [Abstract] [Full Text] [Related]
5.
Ye H; Li T; Wang H; Wu J; Yi C; Shi J; Wang P; Song C; Dai L; Jiang G; Huang Y; Yu Y; Li J
Front Immunol; 2021; 12():649551. PubMed ID: 33815409
[TBL] [Abstract] [Full Text] [Related]
6. Outcomes of Patients With Advanced Gastrointestinal cancer in Relationship to Opioid Use: Findings From Eight Clinical Trials.
Abdel-Rahman O; Karachiwala H; Easaw JC
J Natl Compr Canc Netw; 2020 May; 18(5):575-581. PubMed ID: 32380454
[TBL] [Abstract] [Full Text] [Related]
7. Nomograms predict survival outcomes for distant metastatic pancreatic neuroendocrine tumor: A population based STROBE compliant study.
Li G; Tian ML; Bing YT; Wang HY; Yuan CH; Xiu DR
Medicine (Baltimore); 2020 Mar; 99(13):e19593. PubMed ID: 32221079
[TBL] [Abstract] [Full Text] [Related]
8. Impact of structured report on the quality of preoperative CT staging of pancreatic ductal adenocarcinoma: assessment of intra- and inter-reader variability.
Dimarco M; Cannella R; Pellegrino S; Iadicola D; Tutino R; Allegra F; Castiglione D; Salvaggio G; Midiri M; Brancatelli G; Vernuccio F
Abdom Radiol (NY); 2020 Feb; 45(2):437-448. PubMed ID: 31686180
[TBL] [Abstract] [Full Text] [Related]
9. Adjuvant chemotherapy versus chemoradiation in high-risk pancreatic adenocarcinoma: A propensity score-matched analysis.
Raoof M; Blakely AM; Melstrom LG; Lee B; Warner SG; Chung V; Singh G; Chen YJ; Fong Y
Cancer Med; 2019 Oct; 8(13):5881-5890. PubMed ID: 31414566
[TBL] [Abstract] [Full Text] [Related]
10. Elastography in the diagnosis of pancreatic Malignancies.
Dyrla P; Gil J; Niemczyk S; Saracyn M; Kosik K; Czarkowski S; Lubas A
Adv Exp Med Biol; 2019; 1133():41-48. PubMed ID: 30443726
[TBL] [Abstract] [Full Text] [Related]
11. High levels of serum glypican-1 indicate poor prognosis in pancreatic ductal adenocarcinoma.
Zhou CY; Dong YP; Sun X; Sui X; Zhu H; Zhao YQ; Zhang YY; Mason C; Zhu Q; Han SX
Cancer Med; 2018 Nov; 7(11):5525-5533. PubMed ID: 30358133
[TBL] [Abstract] [Full Text] [Related]
12. Rationale and feasibility of mucin expression profiling by qRT-PCR as diagnostic biomarkers in cytology specimens of pancreatic cancer.
Wiktorowicz M; Mlynarski D; Pach R; Tomaszewska R; Kulig J; Richter P; Sierzega M
Pancreatology; 2018 Dec; 18(8):977-982. PubMed ID: 30268674
[TBL] [Abstract] [Full Text] [Related]
13. Use of proton pump inhibitors and risk of pancreatic cancer.
Hicks B; Friis S; Pottegård A
Pharmacoepidemiol Drug Saf; 2018 Aug; 27(8):926-930. PubMed ID: 29923251
[TBL] [Abstract] [Full Text] [Related]
14. Chemotherapy Use, End-of-Life Care, and Costs of Care Among Patients Diagnosed With Stage IV pancreatic cancer.
Bao Y; Maciejewski RC; Garrido MM; Shah MA; Maciejewski PK; Prigerson HG
J Pain Symptom Manage; 2018 Apr; 55(4):1113-1121.e3. PubMed ID: 29241809
[TBL] [Abstract] [Full Text] [Related]
15. Growth differentiation factor (GDF-15) concentration combined with Ca125 levels in serum is superior to commonly used cancer biomarkers in differentiation of pancreatic mass.
Hogendorf P; Durczyński A; Skulimowski A; Kumor A; Poznańska G; Strzelczyk J
Cancer Biomark; 2018 Feb; 21(3):505-511. PubMed ID: 29171983
[TBL] [Abstract] [Full Text] [Related]
16. Immortal time bias in pharmacoepidemiological studies on cancer patient survival: empirical illustration for beta-blocker use in four cancers with different prognosis.
Weberpals J; Jansen L; van Herk-Sukel MPP; Kuiper JG; Aarts MJ; Vissers PAJ; Brenner H
Eur J Epidemiol; 2017 Nov; 32(11):1019-1031. PubMed ID: 28864947
[TBL] [Abstract] [Full Text] [Related]
17. Glucagon-Like Peptide-1 Receptor PET/CT with 68Ga-NOTA-Exendin-4 for Detecting Localized Insulinoma: A Prospective Cohort Study.
Luo Y; Pan Q; Yao S; Yu M; Wu W; Xue H; Kiesewetter DO; Zhu Z; Li F; Zhao Y; Chen X
J Nucl Med; 2016 May; 57(5):715-20. PubMed ID: 26795291
[TBL] [Abstract] [Full Text] [Related]
18. Non-steroidal anti-inflammatory drugs and pancreatic cancer risk: a nested case-control study.
Bradley MC; Hughes CM; Cantwell MM; Napolitano G; Murray LJ
Br J Cancer; 2010 Apr; 102(9):1415-21. PubMed ID: 20372155
[TBL] [Abstract] [Full Text] [Related]
